These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3871120)

  • 61. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
    Schinelli S; Zuddas A; Kopin IJ; Barker JL; di Porzio U
    J Neurochem; 1988 Jun; 50(6):1900-7. PubMed ID: 3259619
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
    Kelly E; Jenner P; Marsden CD
    J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine.
    Kindt MV; Heikkila RE; Nicklas WJ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):858-63. PubMed ID: 3498818
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ
    Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542
    [TBL] [Abstract][Full Text] [Related]  

  • 65. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the rat.
    Harik SI; Schmidley JW; Iacofano LA; Blue P; Arora PK; Sayre LM
    J Pharmacol Exp Ther; 1987 May; 241(2):669-76. PubMed ID: 2437293
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse.
    Hallman H; Lange J; Olson L; Strömberg I; Jonsson G
    J Neurochem; 1985 Jan; 44(1):117-27. PubMed ID: 3880581
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase-catalyzed oxidation of MPTP analogs.
    Youngster SK; Nicklas WJ; Heikkila RE
    J Pharmacol Exp Ther; 1989 Jun; 249(3):829-35. PubMed ID: 2786565
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacological interference with the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in the mouse.
    Sundström E; Jonsson G
    Eur J Pharmacol; 1985 Apr; 110(3):293-9. PubMed ID: 3874083
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes.
    Willoughby J; Cowburn RF; Hardy JA; Glover V; Sandler M
    J Neurochem; 1989 Feb; 52(2):627-31. PubMed ID: 2783454
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MPTP causes a non-reversible depression of synaptic transmission in mouse neostriatal brain slice.
    Wilson JA; Wilson JS; Weight FF
    Brain Res; 1986 Mar; 368(2):357-60. PubMed ID: 3008929
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
    Joyce JN; Woolsey C; Ryoo H; Borwege S; Hagner D
    BMC Biol; 2004 Oct; 2():22. PubMed ID: 15473914
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Youngster SK; Sonsalla PK; Heikkila RE
    J Neurochem; 1987 Mar; 48(3):929-34. PubMed ID: 3492590
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Potent neurotoxic fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs as potential probes in models of Parkinson disease.
    Riachi NJ; Arora PK; Sayre LM; Harik SI
    J Neurochem; 1988 Apr; 50(4):1319-21. PubMed ID: 3258018
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine reduces the release of [3H]dopamine from rat striatal slices.
    Kurstjens NP; Cantrill RC
    Eur J Pharmacol; 1989 Oct; 169(1):147-52. PubMed ID: 2574687
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inhibition of uptake of 1-methyl-4-phenylpyridinium ion and dopamine in striatal synaptosomes by tobacco smoke components.
    Carr LA; Basham JK; York BK; Rowell PP
    Eur J Pharmacol; 1992 May; 215(2-3):285-7. PubMed ID: 1396992
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).
    Jarvis MF; Wagner GC
    Neuropharmacology; 1985 Jun; 24(6):581-3. PubMed ID: 3875054
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment.
    Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP
    Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced dopamine D2 receptor hypersensitivity in the mouse is transient.
    Peroutka SJ; DeLanney L; Irwin I; Ison PJ; Ricaurte G; Schlegel JR; Langston JW
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):163-71. PubMed ID: 3875136
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 1-Methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in culture.
    Mytilineou C; Cohen G; Heikkila RE
    Neurosci Lett; 1985 Jun; 57(1):19-24. PubMed ID: 3875812
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation products.
    Drucker G; Raikoff K; Neafsey EJ; Collins MA
    Brain Res; 1990 Feb; 509(1):125-33. PubMed ID: 2137718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.